The Numbers: The Thalidomide Trust

The figures behind the charity

£12.4m - The charity's income for the financial year ending 5 April 2009, broadly in line with its income in the previous year

£7.4m - The sum received from drinks firm Diageo in the financial year. It contributes annually to the trust, which was set up after a settlement with Distillers (Biochemicals), the firm that distributed Thalidomide in the UK, now owned by Diageo

466 - The number of beneficiaries the charity helps

£9.96m - Total grants made by the trust in the year, compared with £13.1m the year before

-18.1% - Total return on the charity's investments in the financial year. The value of assets fell from £120.1m to £97.1m

£282k - The cost of investment management during the year

£100k - No employee was paid more than this

10% - Maximum percentage of pensionable income contributed to employees' pension schemes.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus